Lithuania to recognize Covishield, Nuvaxovid coronavirus vaccines

  • 2022-02-02
  • BNS/TBT Staff

VILNIUS – Covishield, AstraZeneca's Indian-manufactured COVID-19 vaccine, and Nuvaxovid, Novavax's jab registered by the European Medicines Agency, will be recognized in Lithuania, the government decided on Wednesday. 

According to Health Minister Arunas Dulkys, Covishield has been approved by the World Health Organization (WHO).

"The WHO has published a document stating that Covishield is fully equivalent to Vaxzevria, except for certain stages of production and the name, so it has been decided to recognize the Covishield vaccine in Lithuania," the minister told the Cabinet. 

This means that "travelers inoculated with the vaccine will not be subject to stricter restrictions on arrival in Lithuania", he added.

Covishield shots are not administered in Lithuania, but AstraZeneca's Vaxzevria vaccine, approved for use in the EU, is available in the country.  

As to Nuvaxovid, the Lithuanian government has decided to purchase 633,000 doses of the vaccine, with the first shots expected to arrive in the country in the first quarter of this year.